Estrella Immunopharma
ESLA
ESLA
10 hedge funds and large institutions have $232K invested in Estrella Immunopharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$25.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
$88.8K |
| 3 |
BlackRock
New York
|
$29K |
| 4 |
Citadel Advisors
Miami,
Florida
|
$16.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
$7.57K |
Top Sellers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
$6.64K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $88.8K | +$21.3K | +18,342 | +32% |
|
|
ASM
2
ATW SPAC Management
New York
| $46.4K | – | – | – |
|
|
3
BlackRock
New York
| $29K | +$20.2K | +17,395 | +230% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $25.2K | +$25.2K | +21,684 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $16.9K | +$16.9K | +14,531 | New |
|
|
MCP
6
Maso Capital Partners
Hong Kong
| $11.6K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $7.57K | +$7.57K | +6,523 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $6.64K | -$1.65K | -1,423 | -20% |
|
9
Bank of America
Charlotte,
North Carolina
| $96 | +$6 | +5 | +6% |
|
10
JPMorgan Chase & Co
New York
| $31 | +$1 | +1 | +4% |
|